P.P. Koopmans

475 total citations
15 papers, 173 citations indexed

About

P.P. Koopmans is a scholar working on Infectious Diseases, Pediatrics, Perinatology and Child Health and Public Health, Environmental and Occupational Health. According to data from OpenAlex, P.P. Koopmans has authored 15 papers receiving a total of 173 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 3 papers in Pediatrics, Perinatology and Child Health and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in P.P. Koopmans's work include HIV/AIDS drug development and treatment (4 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers) and HIV Research and Treatment (2 papers). P.P. Koopmans is often cited by papers focused on HIV/AIDS drug development and treatment (4 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers) and HIV Research and Treatment (2 papers). P.P. Koopmans collaborates with scholars based in Netherlands, United States and Vietnam. P.P. Koopmans's co-authors include J W van der Meer, J. A. Lutterman, T. B. Vree, Jacques F. Meis, Paul E. Verweij, David M. Burger, Y. A. Hekster, Wim J.G. Oyen, Richard M. W. Hoetelmans and Gerrit‐Jan Weverling and has published in prestigious journals such as The Journal of Infectious Diseases, European Journal of Cancer and Journal of Antimicrobial Chemotherapy.

In The Last Decade

P.P. Koopmans

14 papers receiving 162 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P.P. Koopmans Netherlands 8 44 37 34 29 29 15 173
P Bachiller Spain 10 64 1.5× 30 0.8× 31 0.9× 16 0.6× 32 1.1× 33 234
Abdulaziz Hassan Nigeria 9 82 1.9× 39 1.1× 57 1.7× 20 0.7× 21 0.7× 44 271
Raj K. Medapalli United States 6 88 2.0× 36 1.0× 36 1.1× 8 0.3× 46 1.6× 7 240
Claude Scheidegger Switzerland 7 47 1.1× 87 2.4× 8 0.2× 13 0.4× 39 1.3× 13 192
H. Deckx Belgium 11 120 2.7× 24 0.6× 78 2.3× 32 1.1× 10 0.3× 19 323
Angela Aramburo United States 9 24 0.5× 49 1.3× 26 0.8× 14 0.5× 20 0.7× 11 176
Fabian Meienberg Switzerland 8 100 2.3× 46 1.2× 75 2.2× 7 0.2× 7 0.2× 17 277
Sara Bañón Spain 11 152 3.5× 62 1.7× 87 2.6× 34 1.2× 8 0.3× 24 308
Dimitrios Pilalas Greece 10 84 1.9× 66 1.8× 50 1.5× 9 0.3× 9 0.3× 33 238
Rosie Mngqibisa South Africa 8 84 1.9× 50 1.4× 30 0.9× 9 0.3× 17 0.6× 19 134

Countries citing papers authored by P.P. Koopmans

Since Specialization
Citations

This map shows the geographic impact of P.P. Koopmans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.P. Koopmans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.P. Koopmans more than expected).

Fields of papers citing papers by P.P. Koopmans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P.P. Koopmans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.P. Koopmans. The network helps show where P.P. Koopmans may publish in the future.

Co-authorship network of co-authors of P.P. Koopmans

This figure shows the co-authorship network connecting the top 25 collaborators of P.P. Koopmans. A scholar is included among the top collaborators of P.P. Koopmans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P.P. Koopmans. P.P. Koopmans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Porte, Charles la, R.E. Aarnoutse, P.P. Koopmans, et al.. (2005). Pharmacokinetic Interaction Study of Indinavir/Ritonavir and the Enteric‐Coated Capsule Formulation of Didanosine in Healthy Volunteers. The Journal of Clinical Pharmacology. 45(2). 211–218. 6 indexed citations
3.
McCall, Matthew B. B., et al.. (2004). Ocular syphilis acquired through oral sex in two HIV-infected patients.. PubMed. 62(6). 206–8. 6 indexed citations
4.
Koopmans, P.P.. (2002). Clinical endpoints in trials of drugs for cancer: time for a rethink?. BMJ. 324(7350). 1389–1391. 9 indexed citations
5.
Koopmans, P.P., et al.. (2000). [Clinical evaluation of efficacy and adverse effects in the (European) registration of drugs: what does it mean for the doctor and patient?].. PubMed. 144(16). 756–61. 3 indexed citations
6.
Loon, F.P.L. van, et al.. (2000). [Critical review of anti-influenza drugs].. PubMed. 144(4). 165–7. 1 indexed citations
7.
Burger, David M., Richard M. W. Hoetelmans, P.P. Koopmans, et al.. (1997). Clinically relevant drug interactions with antiretroviral agents.. PubMed. 2(3). 149–65. 14 indexed citations
8.
Pieters, G, et al.. (1996). Number and Percentage of NK-Cells Are Decreased in Growth Hormone-Deficient Adults. Clinical Immunology and Immunopathology. 78(1). 90–92. 9 indexed citations
9.
Koopmans, P.P., et al.. (1996). Antibiotic Therapy in Diabetic Foot Infection. Diabetic Medicine. 13(S1). S48–51. 19 indexed citations
10.
Koopmans, P.P., et al.. (1995). Preoperatief internistisch consult. 1. Algemene aspecten en beleid bij diabetes mellitus en obstructieve longziekte. Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank. 139. 1019–1023. 1 indexed citations
11.
12.
Verweij, Paul E., et al.. (1994). Endophthalmitis as presenting symptom of group G streptococcal endocarditis. Infection. 22(1). 56–57. 15 indexed citations
13.
Koopmans, P.P., et al.. (1994). Drug intolerance in HIV disease. Journal of Antimicrobial Chemotherapy. 34(1). 1–5. 29 indexed citations
14.
Frissen, P. H. J., Marc van der Valk, Chris H.H. ten Napel, et al.. (1994). Zidovudine and Interferon-  Combination Therapy versus Zidovudine Monotherapy in Subjects with Symptomatic Human Immunodeficiency Virus Type 1 Infection. The Journal of Infectious Diseases. 169(6). 1351–1355. 28 indexed citations
15.
Koopmans, P.P., et al.. (1993). Control of nausea and vomiting with ondansetron in patients treated with intensive non-cisplatin chemotherapy for acute myeloid leukaemia. European Journal of Cancer. 29(4). 515–518. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P Bachiller Breakdown of academic impact, for papers by Abdulaziz Hassan Breakdown of academic impact, for papers by Raj K. Medapalli Breakdown of academic impact, for papers by Claude Scheidegger Breakdown of academic impact, for papers by H. Deckx Breakdown of academic impact, for papers by Angela Aramburo Breakdown of academic impact, for papers by Fabian Meienberg Breakdown of academic impact, for papers by Sara Bañón Breakdown of academic impact, for papers by Dimitrios Pilalas Breakdown of academic impact, for papers by Rosie Mngqibisa
Rankless by CCL
2026